In Brief: Bard's Telescope
This article was originally published in The Gray Sheet
Executive Summary
Bard's Telescope: Single-operator, over-the-wire balloon catheter is approved by FDA for use in coronary angioplasty. The company says it plans a domestic launch of the product in early 1998 and outside the U.S. "when production volumes permit." Components in the device shaft facilitate length adjustment of the catheter while "anti-backbleed" and "wirelock" features help prevent blood loss during angioplasty procedures, Bard claims...
You may also be interested in...
Amarin Pulls Insurer Into Hikma/Vascepa Induced Infringement Suit
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Dutch Supplements Firm Caught Buying Fake Instagram Followers
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.
Can Biosimilar Orphans Increase Health System Sustainability In The UK?
Developing biosimilar orphan drugs is fraught with challenges and needs buy-in from regulators, developers, patients and clinicians.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: